# Phase II Study of Stereotypes and Mental Retardation: Neurobiological Basis

> **NCT00004300** · PHASE2 · SUSPENDED · sponsor: **Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)** · enrollment: 40 (—)

## Conditions studied

- Stereotyped Behavior
- Mental Retardation

## Interventions

- **DRUG:** bromocriptine
- **DRUG:** sertraline hydrochloride

## Key facts

- **NCT ID:** NCT00004300
- **Lead sponsor:** Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 40 (—)
- **Last updated:** 2010-10-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004300, "Phase II Study of Stereotypes and Mental Retardation: Neurobiological Basis". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00004300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*